Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, Sun Pharma Advanced Research Company has informed that a meeting of the Board of Directors of the Company will be held on Saturday, 5th August, 2017, to consider and take on record, the unaudited financial results of the Company for the quarter ended 30th June 2017. Further, kindly note that pursuant to the Company’s Code of Internal Procedures and Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons shall be closed from Thursday, 27th July 2017 to Tuesday, 8th August, 2017.
The above information is a part of company’s filings submitted to BSE.
